Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Growth Hormone Deficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT00720902
What this trial is testing

Adult Growth Hormone Deficiency and Cardiovascular Risk

Who this might be right for
Growth Hormone Deficiency
Columbia University 7
Early research (Phase 1)Study completedNCT06385145
What this trial is testing

A Bioavailability Study of Two Different PEG-rhGH Preparations.

Who this might be right for
Pediatric Growth Hormone Deficiency (PGHD)
Changchun GeneScience Pharmaceutical Co., Ltd. 16
Not applicableUnknownNCT01804413
What this trial is testing

Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency

Who this might be right for
Adults Growth Hormone Deficiency.
Oregon Health and Science University 10
Not applicableLooking for participantsNCT06694506
What this trial is testing

BELux Children OutcoME During A(@)Dulthood With GHD

Who this might be right for
Growth Hormone DeficiencyAdult Growth Hormone Deficiency
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 200
Large-scale testing (Phase 3)Study completedNCT00570011
What this trial is testing

Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients

Who this might be right for
Growth Hormone Deficiency
Eli Lilly and Company 112
Large-scale testing (Phase 3)Study completedNCT01060488
What this trial is testing

Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
Merck KGaA, Darmstadt, Germany 69
Early research (Phase 1)Study completedNCT00931476
What this trial is testing

A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin

Who this might be right for
Growth Hormone DisorderAdult Growth Hormone DeficiencyHealthy
Novo Nordisk A/S 86
Not applicableEnded earlyNCT00468624
What this trial is testing

Effect of Pegvisomant on GH/IGF-I Relationship in GHD

Who this might be right for
Severe Adult Growth Hormone Deficiency
The Christie NHS Foundation Trust
Large-scale testing (Phase 3)Study completedNCT00596037
What this trial is testing

Treatment of Adults With Growth Hormone Deficiency

Who this might be right for
Pituitary DisordersAdult Growth Hormone Deficiency
LG Life Sciences 136
Large-scale testing (Phase 3)Ended earlyNCT01237340
What this trial is testing

Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study

Who this might be right for
Growth Hormone Deficiency (GHD)
EMD Serono 59
Not applicableStudy completedNCT00459940
What this trial is testing

The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients

Who this might be right for
Growth Hormone Deficiency
University of Aarhus 20
Large-scale testing (Phase 3)Study completedNCT02558829
What this trial is testing

Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency With Pituitary Anomalies
AEterna Zentaris 157
Large-scale testing (Phase 3)Study completedNCT02693522
What this trial is testing

Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
Daewoong Pharmaceutical Co. LTD. 52
Not applicableEnrolling By InvitationNCT05718570
What this trial is testing

Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Information

Who this might be right for
Adult Growth Hormone Deficiency
Novo Nordisk A/S 400
Not applicableActive Not RecruitingNCT05230550
What this trial is testing

Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®

Who this might be right for
Adult Growth Hormone Deficiency
Novo Nordisk A/S 200
Large-scale testing (Phase 3)Ended earlyNCT02410343
What this trial is testing

Study of TV-1106 in Growth Hormone-Deficient Adults

Who this might be right for
Growth Hormone Deficiency
Teva Branded Pharmaceutical Products R&D, Inc. 14
Large-scale testing (Phase 3)Study completedNCT00294619
What this trial is testing

Treatment of Adults With Growth Hormone Deficiency

Who this might be right for
Pituitary DisordersAdult Growth Hormone Deficiency
LG Life Sciences 147
Not applicableStudy completedNCT00711061
What this trial is testing

Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy

Who this might be right for
Growth Hormone Deficiency
Children's Mercy Hospital Kansas City 24
Testing effectiveness (Phase 2)Study completedNCT01811576
What this trial is testing

Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
Teva Branded Pharmaceutical Products R&D, Inc. 52
Early research (Phase 1)Study completedNCT01514500
What this trial is testing

First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects

Who this might be right for
Growth Hormone DisorderAdult Growth Hormone DeficiencyGrowth Hormone Deficiency in Children+1 more
Novo Nordisk A/S 105
Next Page